Endometrial Neoplasms: all 1,347 studies
Page 2 of 14. Open to participants first (452), then studies with results posted, then the rest; newest registration first within each.
- Comparative Study on the Effect of Diet Interventions on Weight Loss in Overweight Endometrial Cancer Patients Undergoing Fertility-sparing TreatmentRecruitingNCT07318727Not applicable
- A Study of Multiparametric Ultrasound Imaging (mpUS) for People With Endometrial CancerRecruitingNCT07318415Not applicable
- GYNORYLAQ™-VLINIVAL™: Ψ-Guided Personalized Neoantigen Peptide Vaccine for High-Risk Endometrial CancerEnrolling by invitationNCT07316361Early Phase 1
- A Study to Test How Well Different Doses of BI 3820768 Are Tolerated by People With Advanced Cancer (Solid Tumours)RecruitingNCT07306559Phase 1
- Cervical Cytology DNA Methylation for Endometrial Lesion Screening and Follow-upNot yet recruitingNCT07298707
- A Study to Investigate Mocertatug Rezetecan Compared With Chemotherapy in Participants With Endometrial Cancer After Platinum-based Chemotherapy and Immunotherapy (BEHOLD-Endometrial01)RecruitingNCT07286331Phase 3
- The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding AreasRecruitingNCT07285044Phase 2
- Low Dose Aspirin to Lower Inflammation and Prevent Endometrial Cancer in Postmenopausal Women With Non-atrophic Endometrial Changes and PainNot yet recruitingNCT07281547Phase 4
- CYTALUX for Intraoperative Imaging of Patients With Endometrial CancerRecruitingNCT07278986Early Phase 1
- ctDNA Testing to Inform Standard-of-Care Treatment Decisions in People With Endometrial CancerRecruitingNCT07270666Not applicable
- Contribution of Oncovascular Surgery in the Treatment of Gynecological Advanced Malignant Diseases.Not yet recruitingNCT07267780
- EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) TumorsRecruitingNCT07262619Phase 1/2
- Generation of Endometrial Carcinoma OrganoidsRecruitingNCT07258186
- A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid TumorsRecruitingNCT07229313Phase 1
- A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic CancerRecruitingNCT07227168Phase 1
- Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized TrialRecruitingNCT07227077Not applicable
- The Better, Harder, Faster, Stronger StudyRecruitingNCT07220512
- Menstrual Cup for Early Endometrial Cancer Detection in Lynch SyndromeRecruitingNCT07220239Not applicable
- The Use of a Novel Vaginal Speculum for Endometrial BiopsiesEnrolling by invitationNCT07217353Not applicable
- FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid TumorsRecruitingNCT07216105Phase 1
- Karyopharm Expanded Access Program for SelinexorAvailableNCT07215832
- A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid TumorsRecruitingNCT07213609Phase 1/2
- A Study of Elacestrant Alone or in Combination With Abemaciclib in People With Endometrial CancerRecruitingNCT07209449Phase 2
- Individualised Endometrial Cancer Risk Stratification by Bayesian Prediction Model (ENDORISK), Optimizing Clinical ImplementationRecruitingNCT07200466Not applicable
- Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial CancerRecruitingNCT07198074Phase 3
- A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid MalignanciesRecruitingNCT07197554Phase 1
- Assessing Uterine Cancer Risk in Lynch Syndrome Carriers Using Vaginal Self-sampling and a Health QuestionnaireRecruitingNCT07194551Not applicable
- 177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid TumorsRecruitingNCT07189871Phase 1/2
- Plant-Based Nutrition for Breast or Endometrial CancerNot yet recruitingNCT07189702Not applicable
- A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9RecruitingNCT07186842Phase 1/2
- A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid TumorsRecruitingNCT07182149Phase 1
- Fruquintinib Combined With Standard Chemotherapy Versus Standard Chemotherapy as First-line Treatment for Advanced pMMR Endometrial CancerNot yet recruitingNCT07170982Phase 2
- Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial CancerRecruitingNCT07166094Phase 3
- Development of a Non-invasive IVD for Endometrial Cancer Screening on High-risk PopulationsRecruitingNCT07148154
- Study of EV for Recurrent Endometrial CarcinomaRecruitingNCT07139977Phase 2
- DESTINY-PANTUMOUR04RecruitingNCT07124000
- Clinical Research on Moderately Hypofractionated Adaptive Postoperative Radiotherapy for High-Risk Endometrial CancerRecruitingNCT07116213Not applicable
- pReOperative Dostarlimab and Novel Therapies in EndOmetrial CancerNot yet recruitingNCT07115927Phase 2
- The Role of POLE Mutation in High Risk Endometrial Cancer.RecruitingNCT07114653
- A Study of LY4257496 in Participants With Cancer (OMNIRAY)RecruitingNCT07114601Phase 1
- A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway AlterationsRecruitingNCT07109726Phase 1/2
- A Study of Dostarlimab in Combination With Carboplatin-paclitaxel in Chinese Participants With Primary Advanced or Recurrent Endometrial Cancer (EC)RecruitingNCT07108270Phase 2
- A Study to Estimate Early Clinical Efficacy Signals of GLP-1 Agonist Administration in Conjunction With Levonorgestrel Intrauterine Device in Obese Patients With Endometrioid Intraepithelial NeoplasiaRecruitingNCT07107334Phase 2
- A Study of GV20-0251 in Advanced or Refractory Solid TumorsRecruitingNCT07106827Phase 1
- Emergence of Bacterial Resistance to Antibiotics in the Digestive Microbiota of Patients Treated With Anticancer DrugsNot yet recruitingNCT07093593Not applicable
- Multimedia Aid for Genetic Testing in Gynecologic OncologyRecruitingNCT07084168Not applicable
- Tirzepatide in Women With Obesity and Endometrial Intra-epithelial Neoplasia or Grade 1 Endometrial CancerNot yet recruitingNCT07078838Phase 2
- Surgical and Obstetric Outcomes in Endometrial Adenocarcinoma and Atypical Endometrial Hyperplasia With Conservative TreatmentRecruitingNCT07077876
- Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment DisorderRecruitingNCT07072728Phase 2
- Study of GV20-0251 in Participants With Solid Tumor MalignanciesRecruitingNCT07070518Phase 1/2
- Prevalence of Germline Alterations in Actionable Genes in Endometrial CancerNot yet recruitingNCT07066969Not applicable
- Tirzepatide in Obesity-Driven Endometrial CancerRecruitingNCT07065552Early Phase 1
- Molecular and ctDNA Characterization of High-Risk Endometrial CancerRecruitingNCT07062016
- Distance-Based Exercise to Preserve Function and Prevent DisabilityRecruitingNCT07059884Not applicable
- A Study of BL-B01D1 + Pembrolizumab ± Bevacizumab in Patients With Recurrent or Metastatic Cervical Cancer and Endometrial CancerRecruitingNCT07054567Phase 2
- Cohort Study of Intrauterine DiseasesRecruitingNCT07048327
- A Study of LY4175408 in Participants With Advanced CancerRecruitingNCT07046923Phase 1
- Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)RecruitingNCT07044336Phase 3
- An Observational Study of Molecular profIling of Advanced and aggRessive ENdometrial Cancer and 1-st Line Treatment Approaches in Russian FederationRecruitingNCT07041606
- Comparison of Two-Position and Four-Position Cervical Injection Techniques for Sentinel Lymph Node Mapping in Endometrial Cancer Using Methylene BlueRecruitingNCT07040657Not applicable
- Ultrasound and Histology in AEH and Early EEC Treated ConservativelyNot yet recruitingNCT07028242
- Ultrasound Training Program for Gynecologic Cancer Staging in ResidentsNot yet recruitingNCT07028229Not applicable
- Application of da Vinci SP for Endometrial Cancer Surgical StagingRecruitingNCT07027046
- Metabolic Effect of Exercise and Diet in Endometrial Cancer Patients Eligible for Staging Surgery.RecruitingNCT07025213Not applicable
- Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial CancerRecruitingNCT07022483Phase 3
- A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid TumorsRecruitingNCT07020221Phase 1/2
- Patient Journey in Advanced Gynecologic CancersNot yet recruitingNCT07015593
- Clinical Trial to Assess the Efficacy of Dostarlimab as Neoadjuvant Therapy in Patients With MMRd/MSI-H Stage II-III Endometrial CancerNot yet recruitingNCT07013851Phase 2
- Precision Medicine Applied to the Study of Endometrial Cancer: Application of NGS for Molecular ClassificationNot yet recruitingNCT07006103
- A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory CarcinomasRecruitingNCT06999187Phase 1
- Durvalumab With or Without Olaparib in Patients With Endometrial Cancers Regulatory Post Marketing SurveillanceRecruitingNCT06995833
- Phase 1/2 Study of ETX-636 in Participants With Advanced Solid TumorsRecruitingNCT06993844Phase 1/2
- Harnessing the Disease Signatures From Endometrium and Menstrual Blood to Identify Avenues for the Treatment of Chronic Conditions Such as Endometriosis and Related Pathologies: This is an Observational Study Aimed at Shedding Light on Women's HealthNot yet recruitingNCT06990971
- DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial CancerRecruitingNCT06989112Phase 3
- Proactive Immune Tolerance Induction in Chemotherapy for Gynecologic CancerRecruitingNCT06977594Not applicable
- Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid TumorsRecruitingNCT06974110Phase 1
- A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)RecruitingNCT06952504Phase 3
- A Study of MT-4561 in Patients With Various Advanced Solid TumorsRecruitingNCT06943521Phase 1/2
- Calcium Channel Blocker Amlodipine for Endometrial Cancer TherapyNot yet recruitingNCT06942377Phase 2
- OSNA Versus Ultrastaging to Detect Sentinel Lymph Node Metastasis in Endometrial CancerRecruitingNCT06935305Not applicable
- A Study of Ivonescimab in People With Endometrial and Cervical CancersRecruitingNCT06925724Phase 2
- QL1706-Based Therapy Post-PD-1/L1 Failure in Advanced Endometrial CancerRecruitingNCT06917092Phase 2
- TQB2450 Plus Progestin for Fertility-sparing Treatment in MMRd ECRecruitingNCT06914297Phase 2
- Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological CancersRecruitingNCT06906341Phase 2
- Application-Assisted Weight Management in Endometrial Cancer Fertility PreservationNot yet recruitingNCT06901778Not applicable
- SENTInel Node Mapping Versus Comprehensive Lymphadenectomy in p53-Mutated Endometrial Cancer: A Non-Inferiority Randomized TrialNot yet recruitingNCT06900582Not applicable
- A Study to Evaluate the Safety of Dostarlimab in Adult Participants in India With Recurrent or Advanced Endometrial Cancer (EC)Not yet recruitingNCT06897527Phase 4
- Assessment of the Effectiveness of the Metabolomic Approach in Screening for Endometrial CancerRecruitingNCT06893861
- NIS to Examine the Effectiveness and Safety of Durvalumab and Olaparib in Patients With Endometrial Cancer (DUOLife)RecruitingNCT06890273
- Lipid Mediators & Cancer: Montelukast, SPM, and AlmondsNot yet recruitingNCT06887673Early Phase 1
- Near-Infrared Fluorescence Imaging With Indocyanine Green to Evaluate Bowel Anastomoses in Gynecologic Oncology SurgeryNot yet recruitingNCT06871787Phase 4
- Comparison of Transvaginal Paracervical and Transperitoneal Approaches in Lymphadenectomy During v-NOTES Surgery for Patients Diagnosed With Endometrial CancerRecruitingNCT06870903Not applicable
- Prognosis of METTL-14 in Endometrial CarcinomaNot yet recruitingNCT06861855
- An Automated Personalized Physical Activity Intervention to Improve Immune Function and Clinical Outcomes in Stage II-IV Ovarian, Primary Peritoneal or Fallopian Tube Cancer and Newly Diagnosed Endometrial Cancer, Life on the Go 3 StudyRecruitingNCT06855706Not applicable
- Trop2-targeted immunoPET Imaging of Solid TumorsRecruitingNCT06851663Phase 2/3
- The Clinical Utility of DNA Methylation Testing in Patient-collected Urine and Vaginal Samples to Detect Endometrial Cancer: a Case-control StudyRecruitingNCT06846775
- A.I and Machine Learning Based Risk Prediction Model to Improve the Clinical Management of Endometrial Cancer.RecruitingNCT06841653
- A Study of PHST001 in Advanced Solid TumorsRecruitingNCT06840886Phase 1
- Advancing Care Coordination Between Cancer and Primary Care Teams for Complex Cancer SurvivorsEnrolling by invitationNCT06834204Not applicable
- Evaluating Efficacy and Tolerability of Anticancer Drug Therapies for the Treatment of Gynecologic and Breast CancersRecruitingNCT06800612